These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 359396)

  • 21. Specificity of serotonin inhibition of insulin release from golden hamster pancreas.
    Feldman JM; Lebovitz HE
    Diabetes; 1970 Jul; 19(7):475-9. PubMed ID: 5310620
    [No Abstract]   [Full Text] [Related]  

  • 22. Enhancement of insulin secretion in adult onset diabetics by methysergide maleate: evidence for an endogenous biogenic monoamine mechanism as a factor in the impaired insulin secretion in diabetes mellitus.
    Quickel KE; Feldman JM; Lebovitz HE
    J Clin Endocrinol Metab; 1971 Dec; 33(6):877-81. PubMed ID: 5135627
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of insulin secretion by serotonin and dopamine: species variation.
    Quickel KE; Feldman JM; Lebovitz HE
    Endocrinology; 1971 Nov; 89(5):1295-302. PubMed ID: 5096997
    [No Abstract]   [Full Text] [Related]  

  • 24. Antagonism of catecholamine inhibition of insulin secretion by methysergide.
    Feldman JM; Lebovitz HE
    Experientia; 1972 Apr; 28(4):433-4. PubMed ID: 5036567
    [No Abstract]   [Full Text] [Related]  

  • 25. Monoamines in the pancreatic islets of the mouse. 5-hydroxytryptamine as an intracellular modifier of insulin secretion, and the hypoglycaemic action of monoamine oxidase inhibitors.
    Lundquist I; Ekholm R; Ericson LE
    Diabetologia; 1971 Dec; 7(6):414-22. PubMed ID: 5004176
    [No Abstract]   [Full Text] [Related]  

  • 26. The occurrence of biogenic monoamines in the mammalian endocrine pancreas.
    Cegrell L
    Acta Physiol Scand Suppl; 1968; 314():1-60. PubMed ID: 4973243
    [No Abstract]   [Full Text] [Related]  

  • 27. The significance of 5-hydroxytryptamine for insulin secretion in the mouse.
    Lernmark A
    Horm Metab Res; 1971 Sep; 3(5):305-9. PubMed ID: 4944450
    [No Abstract]   [Full Text] [Related]  

  • 28. Catechol- and indolamines in some endocrine cell systems. An autoradiographical, histochemical and radioimmunological study.
    Tjälve H
    Acta Physiol Scand Suppl; 1971; 360():1-122. PubMed ID: 4933514
    [No Abstract]   [Full Text] [Related]  

  • 29. Electron microscopic cytochemistry of 5-hydroxytryptamine (5-HT) in the beta cells of guinea pig endocrine pancreas.
    Jaim-Etcheverry G; Zieher LM
    Endocrinology; 1968 Nov; 83(5):917-23. PubMed ID: 4879454
    [No Abstract]   [Full Text] [Related]  

  • 30. Dynamics of insulin secretion by the perfused rat pancreas.
    Curry DL; Bennett LL; Grodsky GM
    Endocrinology; 1968 Sep; 83(3):572-84. PubMed ID: 4877098
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of serotonin on in vitro insulin secretion and biosynthesis in mice.
    Gagliardino JJ; Nierle C; Pfeiffer EF
    Diabetologia; 1974 Oct; 10(5):411-4. PubMed ID: 4615963
    [No Abstract]   [Full Text] [Related]  

  • 32. Potentiation of tolbutamide-mediated insulin release in adult onset diabetics by methysergide maleate.
    Baldridge JA; Quickel KE; Feldman JM; Lebovitz HE
    Diabetes; 1974 Jan; 23(1):21-4. PubMed ID: 4588670
    [No Abstract]   [Full Text] [Related]  

  • 33. Potentiation of insulin secretion in vitro by serotonin antagonists.
    Feldman JM; Quickel KE; Lebovitz HE
    Diabetes; 1972 Jul; 21(7):779-88. PubMed ID: 4402679
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanism of epinephrine and serotonin inhibition of insulin release in the golden hamster in vitro.
    Feldman JM; Lebovitz HE
    Diabetes; 1970 Jul; 19(7):480-6. PubMed ID: 4393305
    [No Abstract]   [Full Text] [Related]  

  • 35. Serotonin inhibition of in vitro insulin release from golden hamster pancreas.
    Feldman JM; Lebovitz HE
    Endocrinology; 1970 Jan; 86(1):66-70. PubMed ID: 4311193
    [No Abstract]   [Full Text] [Related]  

  • 36. A serotoninergic mechanism for the control of insulin secretion.
    Feldman JM; Levovitz HE
    Trans Assoc Am Physicians; 1972; 85():279-94. PubMed ID: 4267099
    [No Abstract]   [Full Text] [Related]  

  • 37. Pancreatic biogenic amines and insulin secretion in health and disease.
    Lebovitz HE; Feldman JM
    Fed Proc; 1973 Jul; 32(7):1797-802. PubMed ID: 4198098
    [No Abstract]   [Full Text] [Related]  

  • 38. Beta cell monoamines: further evidence for their role in modulating insulin secretion.
    Wilson JP; Downs RW; Feldman JM; Lebovitz HE
    Am J Physiol; 1974 Aug; 227(2):305-12. PubMed ID: 4152791
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of cyproheptadine administration on insulin secretion in acromegalic, diabetic and normal subjects.
    Feldman JM; Bivens CH; Skyler JS; Lebovitz HE
    Horm Metab Res; 1975 Jul; 7(4):279-83. PubMed ID: 1150128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of metergoline, a powerful and long-acting antiserotoninergic agent, on insulin secretion in normal subjects and in patients with chemical diabetes.
    Pontiroli AE; Viberti GC; Tognetti A; Pozza G
    Diabetologia; 1975 Apr; 11(2):165-7. PubMed ID: 1149950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.